Oliver Lagore Vanvalin Investment Group Novartis Ag Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Novartis Ag stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 200 shares of NVS stock, worth $23,710. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$23,710
Previous $19,000
26.32%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.4 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.23 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.02 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$836 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$802 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $255B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...